Drupal.behaviors.print = function(context) {window.print();window.close();}>
Vermillion Completes Acquisition of Correlogic Ovarian Cancer Dx Business
December 19, 2011
Vermillion Completes Acquisition of Correlogic Ovarian Cancer Dx Business
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
Vermillion Inks CRADA with Army to Evaluate OVA1
April 17, 2013 / GenomeWeb Daily News
Vermillion's Q4 Revenues Increase 152 Percent on OVA1 Sales
March 27, 2012 / GenomeWeb Daily News
Vermillion Posts Q3 Revenue Decline, Acquires Assets of Correlogic
November 9, 2011 / GenomeWeb Daily News
Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor